Irbesartan, sold under the brand name Aprovel among others, is a medication used to treat high blood pressure, heart failure, and diabetic kidney disease...
14 KB (769 words) - 04:28, 6 September 2024
patients intolerant of ACE inhibitor therapy, in particular candesartan. Irbesartan and losartan have trial data showing benefit in hypertensive patients...
52 KB (5,172 words) - 04:23, 6 September 2024
140 on irbesartan) who reached week 36 in the trial. The safety analyses were based on 404 participants (202 each on sparsentan and irbesartan) who received...
13 KB (905 words) - 11:33, 3 October 2024
pimobendan C09CA01 Losartan C09CA02 Eprosartan C09CA03 Valsartan C09CA04 Irbesartan C09CA05 Tasosartan C09CA06 Candesartan C09CA07 Telmisartan C09CA08 Olmesartan...
4 KB (470 words) - 15:39, 25 January 2024
September 2024. Since July 2018, numerous recalls of losartan, valsartan and irbesartan drug products have caused marked shortages of these life saving medications...
41 KB (3,491 words) - 03:50, 30 September 2024
valsartan), Teveten Plus (with eprosartan), Avalide or CoAprovel (with irbesartan), Atacand HCT or Atacand Plus (with candesartan), etc. Beta blockers –...
25 KB (2,237 words) - 22:08, 30 August 2024
and now owned by Mylan. Avalide (Irbesartan), for hypertension, marketed by Bristol-Myers Squibb. Avapro (Irbesartan), for hypertension, marketed by Bristol-Myers...
92 KB (8,811 words) - 00:07, 10 October 2024
reversible, saturable and of high affinity. Losartan, valsartan, candesartan, irbesartan, telmisartan and olmesartan all contain a biphenyl-methyl group. Losartan...
34 KB (3,896 words) - 04:43, 19 September 2024
products: Cardiovascular diseases Avalide (irbesartan/hydrochlorothiazide) – comarketed with Sanofi Avapro (irbesartan) – comarketed with Sanofi Coumadin (warfarin)...
97 KB (7,689 words) - 17:19, 16 October 2024
perindopril) or angiotensin II receptor blockers (ARBs, such as losartan, irbesartan or candesartan) rather than a direct oral renin inhibitor. ACE inhibitors...
18 KB (2,105 words) - 16:43, 19 October 2024
those patients in which losartan is not halting the growth of the aorta, irbesartan has been shown to work and is currently also being studied and prescribed...
12 KB (1,293 words) - 16:18, 11 October 2024
antagonists include losartan, valsartan, azilsartan, candesartan, eprosartan, irbesartan, olmesartan, and telmisartan. They all have the same mechanism of action...
41 KB (3,269 words) - 22:06, 30 August 2024
Candesartan Elisartan Embusartan Eprosartan EXP-3174 Fimasartan Forasartan Irbesartan Losartan Milfasartan Olmesartan Olodanrigan PD123319 Pomisartan Pratosartan...
22 KB (2,510 words) - 04:31, 10 September 2024
Candesartan Elisartan Embusartan Eprosartan EXP-3174 Fimasartan Forasartan Irbesartan Losartan Milfasartan Olmesartan Olodanrigan PD123319 Pomisartan Pratosartan...
22 KB (1,873 words) - 22:03, 30 August 2024
Bröchner-Mortensen J, Gomis R, Andersen S, Arner P (2001). "The effect of irbesartan on the development of diabetic nephropathy in patients with type 2 diabetes"...
13 KB (1,327 words) - 14:56, 16 May 2024
Candesartan Elisartan Embusartan Eprosartan EXP-3174 Fimasartan Forasartan Irbesartan Losartan Milfasartan Olmesartan Olodanrigan PD123319 Pomisartan Pratosartan...
64 KB (7,025 words) - 15:10, 24 September 2024
Angiotensin II Receptor Blocker (ARB) Recalls (Valsartan, Losartan, and Irbesartan)". U.S. Food and Drug Administration (FDA). November 7, 2019. Retrieved...
25 KB (2,372 words) - 07:30, 21 September 2024
activation of angiotensin receptors. azilsartan candesartan eprosartan irbesartan losartan olmesartan telmisartan valsartan fimasartan In 2004, an article...
55 KB (6,271 words) - 19:16, 14 October 2024
Candesartan Elisartan Embusartan Eprosartan EXP-3174 Fimasartan Forasartan Irbesartan Losartan Milfasartan Olmesartan Olodanrigan PD123319 Pomisartan Pratosartan...
14 KB (1,192 words) - 05:32, 13 September 2024
Hydrochloride Ibuprofen Max Idarubicin HCl Ifosfamide Irinotecan Gianvi Irbesartan Junel Kariva Kelnor Lamotrigine Lansoprazole Laquinimod Letrozole Leucovorin...
70 KB (5,752 words) - 21:53, 26 September 2024
Candesartan Elisartan Embusartan Eprosartan EXP-3174 Fimasartan Forasartan Irbesartan Losartan Milfasartan Olmesartan Olodanrigan PD123319 Pomisartan Pratosartan...
6 KB (343 words) - 21:45, 26 August 2024
Inhibitors, such as enalapril Clonidine, an alpha-2 adrenergic agonist Irbesartan, an angiotensin II receptor antagonist Propranolol, a sympatholytic beta...
29 KB (3,098 words) - 12:21, 10 September 2024
Candesartan Elisartan Embusartan Eprosartan EXP-3174 Fimasartan Forasartan Irbesartan Losartan Milfasartan Olmesartan Olodanrigan PD123319 Pomisartan Pratosartan...
19 KB (1,698 words) - 00:27, 2 October 2024
Candesartan Elisartan Embusartan Eprosartan EXP-3174 Fimasartan Forasartan Irbesartan Losartan Milfasartan Olmesartan Olodanrigan PD123319 Pomisartan Pratosartan...
15 KB (1,228 words) - 04:38, 7 March 2024
D; Omboni, S (January 2014). "Zofenopril plus hydrochlorothiazide and irbesartan plus hydrochlorothiazide in previously treated and uncontrolled diabetic...
22 KB (1,941 words) - 19:08, 28 September 2024
Candesartan Elisartan Embusartan Eprosartan EXP-3174 Fimasartan Forasartan Irbesartan Losartan Milfasartan Olmesartan Olodanrigan PD123319 Pomisartan Pratosartan...
17 KB (1,693 words) - 21:42, 18 August 2024
Candesartan Elisartan Embusartan Eprosartan EXP-3174 Fimasartan Forasartan Irbesartan Losartan Milfasartan Olmesartan Olodanrigan PD123319 Pomisartan Pratosartan...
22 KB (2,241 words) - 21:19, 18 October 2024
Candesartan Elisartan Embusartan Eprosartan EXP-3174 Fimasartan Forasartan Irbesartan Losartan Milfasartan Olmesartan Olodanrigan PD123319 Pomisartan Pratosartan...
22 KB (2,320 words) - 13:06, 15 August 2024
certain angiotensin II receptor blockers: losartan, (sensitive substrates) irbesartan. Inhibitors of CYP3A4 are classified by potency: a Strong inhibitor causes...
80 KB (7,794 words) - 21:26, 15 July 2024
IOBITRIDOL 254. IOHEXOL 255. IOPAMIDOL 4 256. IOMEPROL 257. IOPROMIDE 258. IRBESARTAN 259. IRINOTECAN HYDROCHLORIDE 260. IRON PREPARATION FOR PARENTERAL USE...
16 KB (253 words) - 16:47, 23 February 2023